BUSINESS ISSUE A compliance headache with an upside The Physicians Payments Sunshine Act requires pharma and biotech companies to amass and make public promotional spending on health-care professionals and organizations. Most companies have been focusing Sunshine Act compliance efforts on interpreting the law, integrating diverse data systems and managing massive amounts of data. There is an upside: Companies can pair spending data with other information, which can lead to insights for compliance officers (to anticipate risks), marketers (to track efficiency) and account managers (to complete a 360-degree customer view). Unfortunately, this scenario is easier said than done. Meeting the Sunshine Act’s basic reporting requirements entails major investments. Transforming massive am

Join for free to read